131 related articles for article (PubMed ID: 6840620)
1. Two patients with pancreatic apudomas secreting neurotensin and VIP.
Bloom SR; Lee YC; Lacroute JM; Abbass A; Sondag D; Baumann R; Weill JP
Gut; 1983 May; 24(5):448-52. PubMed ID: 6840620
[TBL] [Abstract][Full Text] [Related]
2. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
3. Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.
Long RG; Bryant MG; Yuille PM; Polak JM; Bloom SR
Gut; 1981 Jun; 22(6):505-11. PubMed ID: 7021331
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic apudomas.
Bloom SR; Polak JM; Welbourn RB
World J Surg; 1979 Sep; 3(5):587-95. PubMed ID: 516776
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
[TBL] [Abstract][Full Text] [Related]
7. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
8. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal hormones in clinical disease: recent developments.
Ann Intern Med; 1979 May; 90(5):817-28. PubMed ID: 219742
[TBL] [Abstract][Full Text] [Related]
10. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
11. Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin.
Gutniak M; Rosenqvist U; Grimelius L; Lundberg JM; Hökfelt T; Rökaeus A; Rosell S; Lundqvist G; Fahrenkrug J; Sundblad R; Gutniak E
Acta Med Scand; 1980; 208(1-2):95-100. PubMed ID: 7001860
[TBL] [Abstract][Full Text] [Related]
12. A unique apudoma producing the glucagonoma and gastrinoma syndromes.
Dawson J; Bloom SR; Cockel R
Postgrad Med J; 1983 May; 59(691):315-6. PubMed ID: 6878103
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).
Long RG; Bryant MG; Mitchell SJ; Adrian TE; Polak JM; Bloom SR
Br Med J (Clin Res Ed); 1981 May; 282(6278):1767-71. PubMed ID: 6786616
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
15. VIP: the cause of the watery diarrhoea syndrome.
Modlin IM; Bloom SR; Mitchell S
Adv Exp Med Biol; 1978; 106():195-201. PubMed ID: 213959
[No Abstract] [Full Text] [Related]
16. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.
Tiedemann K; Pritchard J; Long R; Bloom SR
Eur J Pediatr; 1981 Oct; 137(2):217-9. PubMed ID: 6118274
[TBL] [Abstract][Full Text] [Related]
17. WDHA syndrome caused by VIP-producing ganglioneuroblastoma.
Kudo K; Kitajima S; Munakata H; Yagihashi S
J Pediatr Surg; 1982 Aug; 17(4):426-8. PubMed ID: 6288909
[TBL] [Abstract][Full Text] [Related]
18. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal polypeptide-like immunoreactivity in a human neuroblastoma cell line and the coexistence of other neuropeptide immunoreactivity in the cell line.
Yanaihara N; Kobayashi S; Sato H; Yanaihara C; Sakagami M; Sakura N; Hashimoto T; Ishikawa S; Iwanaga T; Fujita T
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():37-42. PubMed ID: 6164547
[TBL] [Abstract][Full Text] [Related]
20. Gut hormone secreting tumours.
Wood SM; Polak JM; Bloom SR
Scand J Gastroenterol Suppl; 1983; 82():165-79. PubMed ID: 6314485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
